[ad_1]
She said: “In response to incorrect information reported by one of the local television channels in a sensitive and accurate file, such as a drug file, and aired on Friday night, the ministry is concerned about first clarifying that no medicine is distributed in Lebanon, as long as it is not subject to the approval of the technical committee of the Ministry. Public health, which includes university professors and experts who are obliged to observe scientific and international standards in the registration of medicines and is based on guarantee safety, efficacy and quality.
He added: “Secondly, the technical committee of the Ministry of Public Health agreed to use LENOMA, after it was ensured that all the conditions were met, especially BE: STUDY OF BIO EQUIVALENCE, that is, the study of the bioequivalence between this drug. and the basic drug that led to the suffocating economic crisis in Lebanon that the required quantity was not available. The gift of the LENOMA drug obtained by the Iranian Ministry of Public Health helped treat large numbers of people who did not show any negative side effect, highlighting that the central laboratory in Iran meets the international requirements to analyze pharmaceutical preparations with the approval of the World Health Organization Premium drugs for supplementary industries BIOSIMILAR BRAND EMA certified anticancer drugs.
And he continued: “Thirdly, the ministry reaffirms that it is working hard to provide what sick citizens need, and seeks to use generic or generic drugs similar to those in Europe and the United States of America to reduce the health bill, especially because the number of people treated at the expense of the ministry has doubled in recent months as a result of the crisis. ” For this reason, the Ministry seeks to rationalize spending and ensure the greatest amount of medicines at reasonable prices, in proportion to its meager budget and does not prevent those who need it from obtaining their medicine, with the need to adhere to the effectiveness and efficiency standards of medications, away from any other consideration.
And the Ministry of Health concluded: “Fourth, as the Ministry of Public Health of Iran and all friendly countries extend its gratitude for your contribution and support in alleviating the pain and suffering of Lebanese society in this difficult period, it wishes that the interested parties distance themselves politically and morally from a sensitive case like that of drugs, with its negative moral and psychological repercussions “.
